Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Aplastic × Radiotherapy × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 12 Prostatic Neoplasms 10 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Glioma 7 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Oropharyngeal Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Rectal Neoplasms 3 Radiation Injuries 3 Esophageal Neoplasms 3 Carcinoma 3 Vaginal Neoplasms 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoma, Follicular 2 Liposarcoma 2

Interventions

11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡